Notably, Research Nester’s projections suggest that the global psychedelic drugs market is poised to transform into a formidable economic force, anticipated to generate a remarkable $12 billion in revenue by the conclusion of 2035. This prediction represents a substantial upswing from the $3 billion valuation recorded in the year 2022.